Article
Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of…
medRxiv · 2024 · Joers, V.; Murray, B. C.; McLaughlin, C.; Oliver, D.; Staley, H.; Coronado, J. E.; Achat-Mendes, C.; Golshani, S.; Kelly, S. D.; Goodson, M.; Lee, D.; Manfredsson, F. P.; Moore, B. M.; Tansey, M. G.
Key facts
| Title | Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathy |
|---|---|
| First author | Joers, V.; Murray, B. C.; McLaughlin, C.; Oliver, D.; Staley, H.; Coronado, J. E.; Achat-Mendes, C.; Golshani, S.; Kelly, S. D.; Goodson, M.; Lee, D.; Manfredsson, F. P.; Moore, B. M.; Tansey, M. G. |
| Journal | medRxiv |
| Published | Mar 23, 2024 |
| DOI | 10.1101/2023.08.25.554814 |
| Devices mentioned | K052076, K072006, K973342 |
| Product codes mentioned | KIE |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1